课题基金 / 基金详情

项目摘要

项目成果

John David Roberts的其他基金

相似基金

相关文献

中文摘要
翻译
临床方案和数据管理共享资源(CPDMSR)提供集中管理
英文摘要
The Clinical Protocol and Data Management Shared Resource (CPDMSR) provides central management and oversight functions for coordinating, facilitating, and reporting on Cancer Center clinical trials as well as support for quality assurance mechanisms. The CPDMSR coordinates closely with the Biostatistics Shared Resource (BSR), the Protocol Review and Monitoring System (PRMS), Data and Safety Monitoring (DSM), the Cancer Research Informatics and Services (CRIS) Shared Resource, and Cancer Center Administration. CPDMSR has four components: ¿ Director ¿ Clinical Trials Office (CTO) ¿ Ten Research Teams (9 discipline-oriented and 1 geographic) ¿ Database Management. These components assist investigators through the following services: ¿ Development and management of sponsor relations (grants, contracts, compliance) ¿ Compliance with internal and external regulatory authorities (PRMS, IRB, NIH, CTEP, FDA, etc.) ¿ Communications ¿ Continuing education with regard to evolving practice and regulatory standards in clinical research ¿ Research nursing and data management oversight ¿ Protocol specific research nursing and data management ¿ Development and maintenance of databases for clinical research (a collaborative effort with the Cancer Research Informatics and Services Shared Resource (CRIS), the Biostatistics Shared Resource (BSR), and Administration).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
  • 批准号:
    8166535
  • 项目类别:
  • 资助金额:
    $2.24万
  • 财政年份:
    2009
  • 负责人:
    John David Roberts
  • 依托单位:
CLINICAL TRIAL: PILOT/PHASE 1 STUDY OF ZOLEDRONIC ACID (ZOMETA ) IN SICKLE CELL
  • 批准号:
    7950882
  • 项目类别:
  • 资助金额:
    $0.09万
  • 财政年份:
    2008
  • 负责人:
    John David Roberts
  • 依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
  • 批准号:
    7950860
  • 项目类别:
  • 资助金额:
    $3.22万
  • 财政年份:
    2008
  • 负责人:
    John David Roberts
  • 依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
  • 批准号:
    7950875
  • 项目类别:
  • 资助金额:
    $2.43万
  • 财政年份:
    2008
  • 负责人:
    John David Roberts
  • 依托单位:
海外基金